Paxlovid (IMAGE) University of Texas at Austin Caption Epidemiology researchers have found that if just 20 percent of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Credit University of Texas at Austin Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.